Literature DB >> 28184994

Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea.

Eun Hye Lee1, Jung Mo Lee1, Young Ae Kang1, Ah Young Leem1, Eun Young Kim1, Ji Ye Jung1, Moo Suk Park1, Young Sam Kim1, Se Kyu Kim1, Joon Chang1, Song Yee Kim2.   

Abstract

OBJECTIVE: South Korea has an increasing prevalence of diabetes and a relatively high burden of tuberculosis. We aimed to determine the prevalence of diabetes in patients with active pulmonary tuberculosis (PTB) and examine the effect of diabetes on tuberculosis treatment outcomes. SETTING AND
DESIGN: Data from patients ≥30 years diagnosed with and treated for PTB between January 2010 and December 2012 at Severance Hospital, a 2000-bed tertiary referral hospital in Seoul, South Korea, were analyzed and compared with data from a contemporaneous general population sample extracted from KNHANES V.
RESULTS: Diabetes prevalence was 24.2% (252/1044) among patients with PTB and 11.6% (1700/14,655) among controls. Diabetes [odds ratios (OR) 2.56, 95% confidence interval (CI) 1.56-4.21, P < 0.001], male sex (OR 1.93, 95% CI 1.08-3.44, P = 0.027), and cavitary disease (OR 2.08, 95% CI 1.29-3.35, P = 0.003) were significant risk factors for 2-month culture positivity. Diabetes was the only factor associated with unsuccessful treatment outcomes (OR 1.67, 95% CI 1.03-2.70, P = 0.039).
CONCLUSION: The prevalence of diabetes was markedly higher in patients with PTB than in a sample of the general South Korean population. Diabetes may delay sputum conversion and adversely affect treatment outcomes; detection and management of diabetes in patients with PTB is crucial.

Entities:  

Keywords:  Diabetes mellitus; Mycobacterium tuberculosis; Sputum culture conversion; Treatment outcomes

Mesh:

Year:  2017        PMID: 28184994     DOI: 10.1007/s00408-017-9978-4

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  27 in total

Review 1.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

2.  Diabetes mellitus and its influence on sputum smear positivity at the 2nd month of treatment among pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: A case control study.

Authors:  Noorsuzana Mohd Shariff; Nazarudin Safian
Journal:  Int J Mycobacteriol       Date:  2015-10-01

3.  Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis.

Authors:  S Yamashiro; K Kawakami; K Uezu; T Kinjo; K Miyagi; K Nakamura; A Saito
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

4.  Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis.

Authors:  C H Wang; C T Yu; H C Lin; C Y Liu; H P Kuo
Journal:  Tuber Lung Dis       Date:  1999

5.  Diabetic control and risk of tuberculosis: a cohort study.

Authors:  Chi C Leung; Tai H Lam; Wai M Chan; Wing W Yew; Kin S Ho; Gabriel M Leung; Wing S Law; Cheuk M Tam; Chi K Chan; Kwok C Chang
Journal:  Am J Epidemiol       Date:  2008-04-08       Impact factor: 4.897

6.  Incidence of pulmonary tuberculosis among diabetics.

Authors:  S J Kim; Y P Hong; W J Lew; S C Yang; E G Lee
Journal:  Tuber Lung Dis       Date:  1995-12

7.  Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus.

Authors:  F Y Chang; M F Shaio
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

8.  Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients.

Authors:  R Singla; N Khan; N Al-Sharif; M O Ai-Sayegh; M A Shaikh; M M Osman
Journal:  Int J Tuberc Lung Dis       Date:  2006-01       Impact factor: 2.373

9.  The epidemiology of diabetes in Korea.

Authors:  Dae Jung Kim
Journal:  Diabetes Metab J       Date:  2011-08-31       Impact factor: 5.376

Review 10.  Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.

Authors:  Christie Y Jeon; Megan B Murray
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069

View more
  5 in total

Review 1.  Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications.

Authors:  Matthew J Magee; Argita D Salindri; Nang Thu Thu Kyaw; Sara C Auld; J Sonya Haw; Guillermo E Umpierrez
Journal:  Curr Diab Rep       Date:  2018-08-09       Impact factor: 4.810

2.  Increased Risk of Incident Diabetes Among Individuals With Latent Tuberculosis Infection.

Authors:  Matthew J Magee; Anjali Khakharia; Neel R Gandhi; Cheryl L Day; Hardy Kornfeld; Mary K Rhee; Lawrence S Phillips
Journal:  Diabetes Care       Date:  2022-04-01       Impact factor: 17.152

3.  Prevalence of diabetes mellitus in newly diagnosed pulmonary tuberculosis in Beira, Mozambique.

Authors:  Damiano Pizzol; Francesco Di Gennaro; Kajal D Chhaganlal; Claudia Fabrizio; Laura Monno; Giovanni Putoto; Annalisa Saracino
Journal:  Afr Health Sci       Date:  2017-09       Impact factor: 0.927

4.  Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study.

Authors:  Monica Sane Schepisi; Assunta Navarra; M Nieves Altet Gomez; Andrii Dudnyk; Anne Margarita Dyrhol-Riise; Jaime Esteban; Pier Francesco Giorgetti; Gina Gualano; Lorenzo Guglielmetti; Jan Heyckendorf; Anna Kaluzhenina; Berit Lange; Christoph Lange; Katerina Manika; Jalal Miah; Zorica Nanovic; Emanuele Pontali; Monica Rios Prego; Ivan Solovic; Simon Tiberi; Fabrizio Palmieri; Enrico Girardi
Journal:  Open Forum Infect Dis       Date:  2018-12-19       Impact factor: 3.835

5.  Tuberculosis associated with diabetes mellitus by age group in Brazil: a retrospective cohort study, 2007-2014.

Authors:  Maria do Socorro Nantua Evangelista; Rosalia Maia; João Paulo Toledo; Ricardo Gadelha de Abreu; Draurio Barreira
Journal:  Braz J Infect Dis       Date:  2020-04-13       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.